XML 143 R129.htm IDEA: XBRL DOCUMENT v3.22.1
Schedule I - Condensed Financial Information of AMERCO (Statements of Cash Flow) (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2020
Cash flow from operating activities:      
Net earnings $ 1,123,286 $ 610,856 $ 442,048
Earnings from consolidated subsidiaries 0 0 0
Adjustments to reconcile net earnings to cash provided by operations:      
Depreciation 696,955 664,001 664,120
Net loss on sales of investments (11,872) (10,058) (13,596)
Deferred income taxes 101,091 68,411 317,893
Net change in other operating assets and liabilities:      
Reinsurance recoverables and trade receivables (9,187) (39,516) 38,129
Prepaid expenses 232,342 94,359 (391,120)
Other assets (2,706) 29,865 (1,295)
Related party assets (10,357) (487) (5,645)
Accounts payable and accrued expenses 28,752 92,925 (4,530)
Net cash provided by operating activities 1,946,235 1,535,395 1,075,513
Cash flow from investing activities:      
Purchases of property, plant and equipment (2,136,537) (1,441,475) (2,309,406)
Proceeds of equity securities 2,046 207 185
Net cash used by investing activities (1,867,176) (1,129,529) (1,766,649)
Cash flow from financing activities:      
Borrowings from credit facilities 1,969,474 922,008 1,121,412
Principal repayments on credit facilities (437,506) (662,588) (349,986)
Debt issuance costs (13,156) (5,793) (5,332)
Common stock dividends paid (29,412) (49,019) (29,404)
Net contribution from (to) related party   0 0
Net Cash Provided by (Used in) Financing Activities 1,433,155 287,353 512,320
Effects of exchange rate on cash (2,089) 6,441 (533)
Increase (decrease) cash and cash equivalents 1,510,125 699,660 (179,349)
Cash and cash equivalents at the beginning of period 1,194,012 494,352 673,701
Cash and cash equivalents at the end of the period 2,704,137 1,194,012 494,352
Amerco [Member]      
Cash flow from operating activities:      
Net earnings 1,123,286 610,856 442,048
Earnings from consolidated subsidiaries (1,011,841) (508,632) (205,940)
Adjustments to reconcile net earnings to cash provided by operations:      
Depreciation 1 1 1
Net loss on sales of investments 292 924 0
Deferred income taxes 106,869 72,407 323,980
Net change in other operating assets and liabilities:      
Prepaid expenses 234,490 88,898 (381,190)
Other assets (4) 0 22
Related party assets (240) (12,000) 0
Accounts payable and accrued expenses 5,461 (4,019) 1,935
Net cash provided by operating activities 458,314 248,435 180,856
Cash flow from investing activities:      
Purchases of property, plant and equipment (11) (3) 0
Proceeds of equity securities 0 0 0
Net cash used by investing activities (11) (3) 0
Cash flow from financing activities:      
Borrowings from credit facilities 1,200,000 200,000 0
Principal repayments on credit facilities 0 (200,000) 0
Debt issuance costs (8,468) (924) 0
Proceeds from (repayments) of intercompany loans (284,438) 211,064 (311,534)
Common stock dividends paid (29,412) (49,019) (29,404)
Net contribution from (to) related party 0 41,199 21,600
Net Cash Provided by (Used in) Financing Activities 877,682 202,320 (319,338)
Effects of exchange rate on cash (1,591) 5,773 4,060
Increase (decrease) cash and cash equivalents 1,334,394 456,525 (134,422)
Cash and cash equivalents at the beginning of period 751,053 294,528 428,950
Cash and cash equivalents at the end of the period $ 2,085,447 $ 751,053 $ 294,528